![]() |
Custom Search
|
A Phase 1, Open-Label, Multiple-Dose, Dose Escalation Study of the Safety and Tolerability of Staphylococcal Protein A in Adult Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Safety and Efficacy of Cellcept and Avonex as ... Read the entire article at Clinical Trials | ||||
|